A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Clinical trial NCT04603833 · UNKNOWN

Trial details

NCT number: NCT04603833
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2020-12-02
Primary completion: 2022-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.